USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 29, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Revenue	876.24	854.5	921.01	998.6	1,186	1,135
Revenue Growth (YoY)	-2.69%	-7.22%	-7.77%	-15.83%	4.57%	6.95%
Cost of Revenue	170.59	161.21	176.69	193.89	217.9	209.11
Gross Profit	705.65	693.29	744.32	804.71	968.57	925.53
Selling, General & Admin	648.33	626.97	651.25	697.1	798.37	749.04
Operating Expenses	648.33	626.97	651.25	697.1	798.37	749.04
Operating Income	57.32	66.32	93.07	107.61	170.19	176.49
Interest Expense	-0.64	-0.28	-0.26	-0.19	-0.06	-0.51
Interest & Investment Income	9.37	11.32	9.64	3.79	2.52	2.54
Other Non Operating Income (Expenses)	-0.07	-1.01	0.01	-2.59	-2.01	-0.57
Pretax Income	65.98	76.35	102.45	108.62	170.64	177.95
Income Tax Expense	31.17	34.29	38.67	39.27	54.14	53.28
Earnings From Continuing Operations	34.81	42.06	63.79	69.35	116.51	124.66
Minority Interest in Earnings	0.08	-0.03	-	-	-	-
Net Income	34.9	42.03	63.79	69.35	116.51	124.66
Net Income to Common	34.9	42.03	63.79	69.35	116.51	124.66
Net Income Growth	-43.66%	-34.11%	-8.02%	-40.48%	-6.54%	24.01%
Shares Outstanding (Basic)	19	19	19	19	20	21
Shares Outstanding (Diluted)	19	19	19	19	20	21
Shares Change (YoY)	-1.19%	-0.95%	0.18%	-5.08%	-4.29%	-6.84%
EPS (Basic)	1.83	2.20	3.31	3.60	5.78	5.89
EPS (Diluted)	1.82	2.19	3.30	3.59	5.73	5.86
EPS Growth	-43.40%	-33.64%	-8.08%	-37.35%	-2.22%	32.88%
Free Cash Flow	49.12	50.92	56.15	93.5	108.46	145.31
Free Cash Flow Per Share	2.57	2.66	2.90	4.84	5.33	6.84
Gross Margin	80.53%	81.13%	80.81%	80.58%	81.64%	81.57%
Operating Margin	6.54%	7.76%	10.11%	10.78%	14.34%	15.55%
Profit Margin	3.98%	4.92%	6.93%	6.94%	9.82%	10.99%
Free Cash Flow Margin	5.61%	5.96%	6.10%	9.36%	9.14%	12.81%
EBITDA	77.04	80.86	105.77	121.01	183.23	190.24
EBITDA Margin	8.79%	9.46%	11.48%	12.12%	15.44%	16.77%
D&A For EBITDA	19.72	14.54	12.7	13.39	13.04	13.75
EBIT	57.32	66.32	93.07	107.61	170.19	176.49
EBIT Margin	6.54%	7.76%	10.11%	10.78%	14.34%	15.55%
Effective Tax Rate	47.24%	44.91%	37.74%	36.15%	31.72%	29.94%
Advertising Expenses	-	4.97	4.76	5.05	12.4	9.85

Updated Apr 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q